CN112218647A - 赤红球菌产品在治疗热损伤中的用途 - Google Patents

赤红球菌产品在治疗热损伤中的用途 Download PDF

Info

Publication number
CN112218647A
CN112218647A CN202080002633.XA CN202080002633A CN112218647A CN 112218647 A CN112218647 A CN 112218647A CN 202080002633 A CN202080002633 A CN 202080002633A CN 112218647 A CN112218647 A CN 112218647A
Authority
CN
China
Prior art keywords
rhodococcus ruber
cell wall
weeks
rhodococcus
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202080002633.XA
Other languages
English (en)
Other versions
CN112218647B (zh
Inventor
盖波
窦春艳
张轶
张国英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Gerui Shite Bio Pharmacy Co ltd
Original Assignee
Liaoning Gerui Shite Bio Pharmacy Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Gerui Shite Bio Pharmacy Co ltd filed Critical Liaoning Gerui Shite Bio Pharmacy Co ltd
Publication of CN112218647A publication Critical patent/CN112218647A/zh
Application granted granted Critical
Publication of CN112218647B publication Critical patent/CN112218647B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

赤红球菌细胞壁或赤红球菌细胞壁骨架在制备治疗热损伤药物中的用途。所述热损伤包括烧伤、烫伤、化学灼伤等。向受试者施用该赤红球菌产品，对热损伤的治疗效果好，且无副作用。

Description

PCT国内申请，说明书已公开。

Claims (9)

  1. PCT国内申请，权利要求书已公开。
CN202080002633.XA 2019-04-24 2020-04-23 赤红球菌产品在治疗热损伤中的用途 Active CN112218647B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2019103331193 2019-04-24
CN201910333119 2019-04-24
PCT/CN2020/086353 WO2020216281A1 (zh) 2019-04-24 2020-04-23 赤红球菌产品在治疗热损伤中的用途

Publications (2)

Publication Number Publication Date
CN112218647A true CN112218647A (zh) 2021-01-12
CN112218647B CN112218647B (zh) 2023-07-04

Family

ID=81846665

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080002633.XA Active CN112218647B (zh) 2019-04-24 2020-04-23 赤红球菌产品在治疗热损伤中的用途

Country Status (6)

Country Link
US (1) US20220175852A1 (zh)
EP (1) EP3960845A4 (zh)
JP (1) JP2022531109A (zh)
KR (1) KR20220004091A (zh)
CN (1) CN112218647B (zh)
WO (1) WO2020216281A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111787931A (zh) * 2019-01-15 2020-10-16 辽宁格瑞仕特生物制药有限公司 分离的赤红球菌细胞壁骨架在制备治疗人乳头瘤病毒感染的药物中的用途

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115484967A (zh) * 2021-03-24 2022-12-16 辽宁格瑞仕特生物制药有限公司 赤红球菌产品在治疗放射病中的用途

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094288A (zh) * 1993-04-23 1994-11-02 福建省微生物研究所 利用红色诺卡氏菌制造细胞壁骨架粉末的方法
JP2002179575A (ja) * 2000-12-12 2002-06-26 Club Cosmetics Co Ltd 皮膚創傷治癒促進物質及び皮膚創傷治療用外用剤
JP2003052362A (ja) * 2001-08-10 2003-02-25 Club Cosmetics Co Ltd 血管内皮細胞増殖促進剤及び血管内皮細胞培養用組成物並びに創傷治癒剤
JP2003052366A (ja) * 2001-08-10 2003-02-25 Club Cosmetics Co Ltd ケラチノサイト増殖促進剤及びケラチノサイト培養用組成物並びに創傷治癒剤
CN101209267A (zh) * 2006-12-29 2008-07-02 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤损伤和疮疡的药物中的用途
CN107233362A (zh) * 2017-06-16 2017-10-10 福建省山河药业有限公司 一种红色诺卡氏菌细胞壁骨架溶媒提取方法
WO2018208530A1 (en) * 2017-05-07 2018-11-15 Locus Ip Company, Llc Cosmetic compositions for skin health and methods of using same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534594A (en) 1994-12-05 1996-07-09 Rohm And Haas Company Preparation of butadiene-based impact modifiers
CN1223673C (zh) 2003-01-23 2005-10-19 中国科学院微生物研究所 一种产生生物乳化剂和降解多环芳烃的赤红球菌Em及用途
CN100519737C (zh) 2006-04-29 2009-07-29 浙江工业大学 赤红球菌zjb-064及其应用
JPWO2007132790A1 (ja) * 2006-05-12 2009-09-24 国立大学法人 北海道大学 細菌菌体成分を含む脂質膜を有するリポソーム
CN101250490A (zh) 2008-03-28 2008-08-27 天津科技大学 活酵母细胞衍生物的生产方法
CN101580808B (zh) 2008-05-15 2011-11-16 汕头大学 一株赤红球菌及其在降解烃类化合物中的应用
CN101323865B (zh) 2008-08-07 2012-07-18 山东省科学院能源研究所 微生物油脂分离提取方法
CN101619299B (zh) 2009-07-08 2012-07-04 天津科技大学 一种赤红球菌以及利用该菌制备5-氰基戊酰胺的方法
CN102250796B (zh) 2011-06-21 2013-11-06 中国农业科学院农业环境与可持续发展研究所 一种赤红球菌和微生物菌剂及它们的应用
CN102604875B (zh) 2012-03-26 2014-12-10 江西师范大学 赤红球菌及其在降解苯酚污染物中的应用
CN103160491B (zh) 2013-04-15 2014-12-10 江西师范大学 赤红球菌sd3的诱变菌m1的固定化细胞及其在降解苯酚污染物中的应用
CN103509833B (zh) 2013-08-15 2016-04-06 天津科技大学 一种利用赤红球菌制备2,6-二氟苯甲酰胺的方法
CN103627653B (zh) 2013-10-17 2016-01-20 浙江省环境保护科学设计研究院 一种赤红球菌菌株及其在含有机污染物的废水处理中的应用
CN105779326A (zh) 2014-12-25 2016-07-20 河南科技学院 化脓性链球菌细胞壁成分萃取方法
CN104830738B (zh) 2015-05-22 2017-09-15 厦门大学 一种赤红球菌及其在制备十溴联苯醚降解剂中的应用
CN106591168B (zh) 2016-02-02 2019-08-16 江苏南资环保科技有限公司 一种烟嘧磺隆降解赤红球菌ymhl-1及其应用
CN106591172B (zh) 2016-04-01 2019-11-29 江苏南资环保科技有限公司 一种赤红球菌pta-2及其固定化和应用
CN105820982B (zh) 2016-04-29 2019-06-28 河北省科学院生物研究所 一种赤红球菌xs-2、其生物菌剂及制备方法和应用
CN106434466B (zh) 2016-10-14 2019-10-18 天津科技大学 一种产生天然红色素的赤红球菌及其制备方法与应用
CN107151635B (zh) 2017-04-28 2020-02-18 中国农业科学院研究生院 一种能够降解邻苯二甲酸酯的赤红球菌及其应用
CN108130288B (zh) 2017-12-15 2020-10-09 浙江工业大学 赤红球菌及其降解有机污染物的应用
CN108862590B (zh) 2018-08-03 2021-01-12 中国石油大学(北京) 一种降解丙烯腈废水cod的方法
CN109576180B (zh) 2018-12-17 2021-11-26 北京利昂盛生物技术有限公司 一株赤红球菌及其作为免疫佐剂在制备疫苗中的应用
US20220241348A1 (en) * 2019-01-15 2022-08-04 Liaoning Greatest Bio-Pharmaceutical Co. Ltd. Product derived from rhodococcus ruber, and pharmaceutical use thereof
WO2020216283A1 (zh) * 2019-04-24 2020-10-29 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗热损伤中的用途

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094288A (zh) * 1993-04-23 1994-11-02 福建省微生物研究所 利用红色诺卡氏菌制造细胞壁骨架粉末的方法
JP2002179575A (ja) * 2000-12-12 2002-06-26 Club Cosmetics Co Ltd 皮膚創傷治癒促進物質及び皮膚創傷治療用外用剤
JP2003052362A (ja) * 2001-08-10 2003-02-25 Club Cosmetics Co Ltd 血管内皮細胞増殖促進剤及び血管内皮細胞培養用組成物並びに創傷治癒剤
JP2003052366A (ja) * 2001-08-10 2003-02-25 Club Cosmetics Co Ltd ケラチノサイト増殖促進剤及びケラチノサイト培養用組成物並びに創傷治癒剤
CN101209267A (zh) * 2006-12-29 2008-07-02 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤损伤和疮疡的药物中的用途
WO2018208530A1 (en) * 2017-05-07 2018-11-15 Locus Ip Company, Llc Cosmetic compositions for skin health and methods of using same
CN107233362A (zh) * 2017-06-16 2017-10-10 福建省山河药业有限公司 一种红色诺卡氏菌细胞壁骨架溶媒提取方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
尤小娜 等: "对胞必佳生产菌株的重新鉴定", 《生物加工过程》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111787931A (zh) * 2019-01-15 2020-10-16 辽宁格瑞仕特生物制药有限公司 分离的赤红球菌细胞壁骨架在制备治疗人乳头瘤病毒感染的药物中的用途

Also Published As

Publication number Publication date
US20220175852A1 (en) 2022-06-09
EP3960845A4 (en) 2022-10-19
CN112218647B (zh) 2023-07-04
EP3960845A1 (en) 2022-03-02
KR20220004091A (ko) 2022-01-11
WO2020216281A1 (zh) 2020-10-29
JP2022531109A (ja) 2022-07-06

Similar Documents

Publication Publication Date Title
CN111801105B (zh) 赤红球菌产品在治疗复发性阿弗他溃疡中的用途
WO2020182180A1 (zh) 赤红球菌产品在治疗外阴白色病变中的用途
CN112218647B (zh) 赤红球菌产品在治疗热损伤中的用途
WO2024027673A1 (zh) 红色诺卡氏菌细胞壁骨架在治疗慢性宫颈炎中的应用
CN112135620A (zh) 红色诺卡氏菌细胞壁骨架在治疗热损伤中的用途
WO2022199453A1 (zh) 赤红球菌产品在治疗放射病中的用途
Shahzad et al. Production of proteases by genetically improved Bacillus subtilis for enhanced skin penetration of antibacterial topical formulation
CN115087729A (zh) 赤红球菌细胞壁骨架在再生医学中的用途
CN101686993A (zh) 卡介菌多糖核酸提取物在制备治疗病毒性皮肤病的药物中的应用及其注射剂和制备方法
CN117338823A (zh) 一种动物酵素发酵液及其制备方法与应用
CN114402064A (zh) 红色诺卡氏菌细胞壁骨架在再生医学中的用途
CN115708835A (zh) 一株可缓解银屑病的短双歧杆菌及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40034285

Country of ref document: HK

CB02 Change of applicant information

Address after: No.1, floor 1, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province

Applicant after: Liaoning Tian'an Biopharmaceutical Co.,Ltd.

Address before: No.1, floor 1, building 8-2, Chun'an street, Shiqiaozi, Xihu District, Benxi City, Liaoning Province

Applicant before: LIAONING GREATEST BIO-PHARMACEUTICAL Co.,Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant